Is it time to move away from short-acting beta-agonists in asthma management?
Open Access
- 4 April 2019
- journal article
- editorial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 53 (4), 1802223
- https://doi.org/10.1183/13993003.02223-2018
Abstract
Frequent SABA use is associated with adverse asthma outcomes and evidence suggests replacing SABA with fast-acting LABA/ICS as reliever therapy reduces asthma exacerbation risk. We believe the time has come to move away from SABAs in asthma management. http://ow.ly/87UJ30nVGNcKeywords
This publication has 26 references indexed in Scilit:
- Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017Thorax, 2019
- Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993–2012)The Lancet, 2017
- Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet Respiratory Medicine, 2017
- The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysisnpj Primary Care Respiratory Medicine, 2017
- The national review of asthma deaths: what did we learn and what needs to change?Breathe, 2015
- Short-acting β-agonist use and its ability to predict future asthma-related outcomesAnnals of Allergy, Asthma & Immunology, 2012
- Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatmentAnnals of Allergy, Asthma & Immunology, 2002
- Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamolJournal of Allergy and Clinical Immunology, 2000
- Epidemiologic Studies of Beta Agonists and Asthma DeathsEpidemiologic Reviews, 1998
- Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic AsthmaBMJ, 1972